|
|
|
| Chronic Severe Constipation: Presentations and Complications |
|
|
|
James C. Reynolds, M.D.
June F. Klinghoffer Distinguished Professor and Chair Department of Medicine Drexel University College of Medicine Philadelphia, PA |
|
|
| Objectives |
• List disorders often categorized as functional and known causes for disorders that may mimic these syndromes • Describe the mechanisms and treatment of chronic severe constipation • List the causes and treatments of functional dysphagia • Outline a cost effective evaluation and treatment of functional causes of early satiety and bloating • Recognize the importance of fecal incontinence and the most effective treatments |
| Target Audience | Internal Medicine, Family Medicine, Physicians Assistants, Registered Nurses and those interested in general medicine topics. |
|
Commercial Support |
• Takeda Pharmaceuticals America, Inc. |
|
Speaker Disclosure |
AstraZeneca, GlaxoSmithKline, TAP Pharmaceuticals, Wyeth-Ayerst Pharmaceutical, Janssen Pharmeceutical - Speaker's Bureau and Honorarium Takeda-Abbot Pharmaceuticals, AstraZeneca Pharmaceuticals, Janssen Pharmeceutical, Wyeth-Ayerst Pharmaceutical, Roche Laboratories, ELAM Pharmaceuticals - Consultant and Research Support The presentation and clinical recommendations reflects the best available evidence from medical literature. |
| Unlabeled Uses | Each faculty person presenting is requested, in writing, to disclose any product that is not labeled for the use under discussion or that the product is still investigational. |
|
This Virtual Grand Rounds presentation is availble as an archive only. |